Abstract:Toll-like receptors (TLRs) belong to a germline-encoded protein family. These are pattern recognition receptors. They sense pathogen-associated molecular patterns (PAMPs). When this occurs, activation of the NF-ĸB pathway follows. This triggers the innate immune response of the host. The consequent inflammatory cytokine response usually contributes to the elimination of the pathogen. Activation of TLRs also induces an adaptive immune response by a cross-prime mechanism. This mechanism is employed in cancer immunotherapy. Using TLR ligands as adjuvants induces upregulation of costimulatory signals which in turn activates a cytotoxic leukocyte response against cancer cells. However, TLRs are also overexpressed in human cancer cells resulting in increased cell proliferation, migration, invasion, and angiogenesis. An intracellular adaptor, myeloid differentiation factor 88 (MyD88) probably mediates this process. MyD88 is intimately involved with all TLRs except TLR3. One consequence of the interaction between a TLR and MyD88 is activation of NF-ĸB. In this context of a variety of proinflammtory cytokines being produced, chronic inflammation may result. Inflammation is an important protective mechanism. However, chronic inflammation is also involved in carcinogenesis. Activation of NF-ĸB inhibits apoptosis and under certain circumstances, tumor cell survival. In this review, the potential therapeutic value of TLRs in immunotherapy and its role in oncogenesis are explored. The emerging use of artificial intelligence is mentioned.

What problem does this paper attempt to address?

The paper primarily explores the dual role of Toll-like receptors (TLRs) in cancer—both potentially anti-cancer and cancer-promoting. Specifically, the paper attempts to answer the following questions: 1. **The role of TLRs in immune response**: TLRs can recognize pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), thereby triggering innate immune responses and inducing adaptive immune responses through cross-activation mechanisms. 2. **The role of TLRs in cancer**: On one hand, activation of TLRs can enhance the killing ability of immune cells against tumor cells; on the other hand, overexpressed TLRs may also promote cancer cell proliferation, migration, and invasion. 3. **The relationship between chronic inflammation and cancer**: The paper discusses how chronic inflammation can lead to the occurrence and development of cancer through TLR-mediated signaling pathways. 4. **The specific roles of different types of TLRs in cancer**: For example, the specific effects and mechanisms of TLR2, TLR3, TLR4, etc., in different types of cancer. 5. **TLRs as potential therapeutic targets**: The paper also explores the possibility of using TLRs as targets for immunotherapy and mentions some clinical trial results. In summary, this review article aims to comprehensively explore the complex roles of TLRs in cancer and their potential therapeutic value.

Multiple Factors Determine the Oncolytic or Carcinogenic Effects of TLRs Activation in Cancer